OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploiting the curative potential of adoptive T‐cell therapy for cancer
Christian S. Hinrichs, Steven A. Rosenberg
Immunological Reviews (2013) Vol. 257, Iss. 1, pp. 56-71
Open Access | Times Cited: 449

Showing 1-25 of 449 citing articles:

Neoantigens in cancer immunotherapy
Ton N. Schumacher, Robert D. Schreiber
Science (2015) Vol. 348, Iss. 6230, pp. 69-74
Open Access | Times Cited: 4320

Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney, Sachet A. Shukla, Catherine J. Wu, et al.
Cell (2015) Vol. 160, Iss. 1-2, pp. 48-61
Open Access | Times Cited: 3317

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
Sattva S. Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Nature Reviews Clinical Oncology (2017) Vol. 15, Iss. 1, pp. 47-62
Open Access | Times Cited: 2013

CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst, Tomasz Ahrends, Nikolina Bąbała, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 10, pp. 635-647
Closed Access | Times Cited: 1281

Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona, Eleftherios P. Diamandis, Ivan M. Blasutig
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 1071

Therapeutic cancer vaccines
Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3401-3412
Open Access | Times Cited: 1038

Cytokines in clinical cancer immunotherapy
Pedro Berraondo, Miguel F. Sanmamed, María C. Ochoa, et al.
British Journal of Cancer (2018) Vol. 120, Iss. 1, pp. 6-15
Open Access | Times Cited: 1007

Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment
Yunlu Dai, Can Xu, Xiaolian Sun, et al.
Chemical Society Reviews (2017) Vol. 46, Iss. 12, pp. 3830-3852
Open Access | Times Cited: 825

Toxicity and management in CAR T-cell therapy
Challice L. Bonifant, Hollie J. Jackson, Renier J. Brentjens, et al.
Molecular Therapy — Oncolytics (2016) Vol. 3, pp. 16011-16011
Open Access | Times Cited: 801

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Thomas Duhen, Rebekka Duhen, Ryan Montler, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 752

TRUCKs: the fourth generation of CARs
Markus Chmielewski, Hinrich Abken
Expert Opinion on Biological Therapy (2015) Vol. 15, Iss. 8, pp. 1145-1154
Closed Access | Times Cited: 601

Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
Sanja Stevanović, Lindsey M. Draper, Michelle M. Langhan, et al.
Journal of Clinical Oncology (2015) Vol. 33, Iss. 14, pp. 1543-1550
Open Access | Times Cited: 581

Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
Xiaoyun Li, Mathias Wenes, Pedro Romero, et al.
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 7, pp. 425-441
Closed Access | Times Cited: 575

Improving cancer immunotherapy through nanotechnology
Michael S. Goldberg
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 587-602
Closed Access | Times Cited: 529

Cancer Neoantigens
Ton N. Schumacher, Wouter Scheper, Pia Kvistborg
Annual Review of Immunology (2018) Vol. 37, Iss. 1, pp. 173-200
Open Access | Times Cited: 459

Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
Aurélie Durgeau, Yasemin Virk, Stéphanie Corgnac, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 435

Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
Émilie Picard, Chris P. Verschoor, W Kitonyi Grace, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 402

Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells
Qian Chen, Quanyin Hu, Elena Dukhovlinova, et al.
Advanced Materials (2019) Vol. 31, Iss. 23
Open Access | Times Cited: 389

Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia
Quanshun Wang, Yao Wang, Haiyan Lv, et al.
Molecular Therapy (2014) Vol. 23, Iss. 1, pp. 184-191
Open Access | Times Cited: 369

Mechanisms regulating T-cell infiltration and activity in solid tumors
Evripidis Lanitis, Denarda Dangaj, Melita Irving, et al.
Annals of Oncology (2017) Vol. 28, pp. xii18-xii32
Open Access | Times Cited: 326

Engineered Cell‐Membrane‐Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity
Yao Jiang, Nishta Krishnan, Jiarong Zhou, et al.
Advanced Materials (2020) Vol. 32, Iss. 30
Open Access | Times Cited: 292

Tissue-resident memory T cells at the center of immunity to solid tumors
Derk Amsen, Klaas P. J. M. van Gisbergen, Pleun Hombrink, et al.
Nature Immunology (2018) Vol. 19, Iss. 6, pp. 538-546
Closed Access | Times Cited: 249

Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy
Marcela V. Maus, Carl H. June
Clinical Cancer Research (2016) Vol. 22, Iss. 8, pp. 1875-1884
Open Access | Times Cited: 247

Driving gene-engineered T cell immunotherapy of cancer
Laura A. Johnson, Carl H. June
Cell Research (2016) Vol. 27, Iss. 1, pp. 38-58
Open Access | Times Cited: 243

Combinational strategy for high-performance cancer chemotherapy
Si‐Yong Qin, Yin‐Jia Cheng, Qi Lei, et al.
Biomaterials (2018) Vol. 171, pp. 178-197
Closed Access | Times Cited: 239

Page 1 - Next Page

Scroll to top